Jeffrey P Weiss Selected Research

Nocturia

6/2022	Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment.
6/2022	Impact of Aging on Urinary Natriuretic Peptides in Nocturia and Nocturnal Polyuria.
6/2021	Phenotyping the Association between Nocturia and Hypertension: A Systematic Review and Meta-Analysis.
1/2021	Nocturia is Associated with High Atherosclerotic Cardiovascular Disease Risk in Women: Results from the National Health and Nutrition Examination Survey.
1/2021	Does traditional pharmacotherapy augment behavioral modification in the treatment of nocturia?
1/2021	Nocturia and electrocardiographic abnormalities among patients at an inner-city cardiology clinic.
12/2020	Nocturia is an Independent Predictor of Abdominal Aortic Calcification in Women: Results from the National Health and Nutrition Examination Survey.
1/2020	Sodium restriction improves nocturia in patients at a cardiology clinic.
1/2020	Nocturia: a marker of furosemide treatment response? An exploratory study.
1/2020	Dietary considerations in the evaluation and management of nocturia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey P Weiss Research Topics

Disease

35	Nocturia 06/2022 - 04/2006
14	Polyuria 06/2022 - 04/2010
8	Overactive Urinary Bladder (Overactive Bladder) 01/2020 - 04/2006
6	Neoplasms (Cancer) 08/2021 - 11/2011
5	Hypertension (High Blood Pressure) 06/2021 - 01/2019
5	Prostatic Neoplasms (Prostate Cancer) 04/2017 - 12/2006
3	Edema (Dropsy) 01/2021 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 11/2019
3	Lower Urinary Tract Symptoms 11/2019 - 12/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 02/2021
2	Obesity 01/2021 - 08/2009
2	Heart Failure 01/2021 - 01/2020
2	Hyponatremia 01/2021 - 04/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020 - 08/2009
2	Diabetes Insipidus 01/2020 - 01/2020
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2014 - 10/2011
1	Inflammation (Inflammations) 03/2022
1	Cognitive Dysfunction 01/2021
1	Delirium 01/2021
1	Diabetes Mellitus 01/2021
1	Pain (Aches) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Essential Hypertension 11/2019
1	Obstructive Sleep Apnea 11/2019
1	Sleep Wake Disorders 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014
1	Penile Neoplasms (Penile Cancer) 01/2014
1	Nocturnal Enuresis (Bedwetting) 12/2013
1	Hemorrhage 12/2013
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 12/2013
1	Restless Legs Syndrome (Restless Legs) 08/2009
1	Urinary Incontinence 08/2007
1	Urethral Obstruction 12/2006
1	Urethral Stricture 12/2006
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 05/2005
1	Pernicious Anemia 05/2005
1	Diarrhea 05/2005
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 05/2005
1	Malabsorption Syndromes (Malabsorption Syndrome) 05/2005

Drug/Important Bio-Agent (IBA)

10	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2021 - 04/2012
8	DiureticsIBA 06/2021 - 01/2019
5	TabletsIBA 01/2020 - 04/2012
4	Arginine Vasopressin (Argipressin)IBA 01/2021 - 11/2019
4	Muscarinic AntagonistsIBA 01/2021 - 04/2013
3	Vasopressins (Vasopressin)IBA 01/2020 - 12/2013
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 06/2022 - 04/2014
2	Hormones (Hormone)IBA 06/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2019
2	ORALIT (ORS)IBA 01/2021 - 12/2020
2	Dietary SodiumIBA 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	SodiumIBA 01/2020 - 01/2020
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 04/2010
2	fesoterodine FDA Link 11/2017 - 04/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2017 - 11/2011
2	Caffeine (No Doz)FDA LinkGeneric 10/2016 - 04/2014
2	Tolterodine Tartrate (Detrol)FDA Link 08/2007 - 04/2006
1	pro-brain natriuretic peptide (1-76)IBA 06/2022
1	Natriuretic PeptidesIBA 06/2022
1	Peptides (Polypeptides)IBA 06/2022
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 12/2020
1	TeaIBA 01/2020
1	Furosemide (Lasix)FDA LinkGeneric 01/2020
1	MelatoninIBA 01/2020
1	ElectrolytesIBA 01/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020
1	Deuterium Oxide (Heavy Water)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019
1	Delayed-Action PreparationsIBA 01/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2016
1	AndrogensIBA 03/2015
1	Tadalafil (Cialis)FDA Link 10/2014
1	Phosphodiesterase 5 InhibitorsIBA 10/2014
1	5-alpha Reductase InhibitorsIBA 04/2010
1	Antidepressive Agents (Antidepressants)IBA 08/2009
1	Parasympatholytics (Antispasmodics)IBA 05/2005

Therapy/Procedure

13	Therapeutics 01/2021 - 05/2005
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
3	Neoadjuvant Therapy 08/2021 - 01/2014
2	Cystectomy 08/2021 - 02/2021
2	Prostatectomy (Retropubic Prostatectomy) 03/2015 - 10/2014
1	Transportation of Patients 08/2021
1	Chemoradiotherapy 01/2021
1	Analgesia 01/2021
1	Length of Stay 01/2021
1	Continuous Positive Airway Pressure 01/2020
1	Diet Therapy (Therapy, Diet) 01/2020
1	Traction 01/2016
1	Radiotherapy 03/2015
1	Brachytherapy 12/2006
1	Urinary Diversion (Ileal Conduit) 05/2005